Intracellular components regulate c-jun gene expression during MMS treatment in NIH3T3 cells.

碩士 === 國立臺灣大學 === 毒理學研究所 === 82 === Exposure of NIH3T3 cells with alkylating agent methyl methane- sulfonate(MMS) leads to the transient induction of c-jun gene. Several lines of evidence have shown that the activation of protein kinases ca...

Full description

Bibliographic Details
Main Authors: Meng Tzu-Ching, 孟子青
Other Authors: Kuo M-L
Format: Others
Language:zh-TW
Published: 1994
Online Access:http://ndltd.ncl.edu.tw/handle/37851586869366903158
Description
Summary:碩士 === 國立臺灣大學 === 毒理學研究所 === 82 === Exposure of NIH3T3 cells with alkylating agent methyl methane- sulfonate(MMS) leads to the transient induction of c-jun gene. Several lines of evidence have shown that the activation of protein kinases can accelerate c-jun mRNA transcription, but our result clearly demonstrated that pretreatment with different kinase inhibitors did not alter the MMS-induced c-jun transcript expression.When both parental NIH3T3 cells and v-Ha- ras transformed NIH3T3 cells are expose to MMS, we found the kinetics of c-jun induction of these two cell lines are the same, but that of DNA damage are quite different. Additionally, benzamide, a specific inhibitor of poly(ADP-ribosyl) transferase, potentiates MMS-induced DNA damage level in NIH3T3 cells but has no significant difference on c-jun mRNA accumulation when comparing with the degree of MMS treated alone. When MMS treatment followed depletion of intracellular GSH by BSO, the induction of c-jun mRNA was inhibited severely. Furthermore, the degree of c-jun induction correlates with the level of intracellular GSH. Finally we suggest the primary message comes from the disturbance of GSH pool. Methylating modification on Cys residue of GSH may be an important intermediate triggering signals to elevating the transcription of c-jun gene.